Neurobehavioral investigation and acetylcholinesterase inhibitory activity study for some new coumarin derivatives.
Autor: | Mahmoud WR; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr Elini St, Cairo, 11562, Egypt. Electronic address: walaa.abozaid@pharma.cu.edu.eg., Nissan YM; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr Elini St, Cairo, 11562, Egypt; Pharmaceutical Chemistry Department, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), Giza, Egypt., Elsawah MM; Drug Research Center, Cairo, Egypt., Refaey RH; Pharmaceutical Chemistry Department, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), Giza, Egypt., Ragab MF; Pharmacology and Toxicology Department, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), Giza, Egypt., Amin KM; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr Elini St, Cairo, 11562, Egypt. |
---|---|
Jazyk: | angličtina |
Zdroj: | European journal of medicinal chemistry [Eur J Med Chem] 2019 Nov 15; Vol. 182, pp. 111651. Date of Electronic Publication: 2019 Aug 28. |
DOI: | 10.1016/j.ejmech.2019.111651 |
Abstrakt: | Twenty four 6-aminocoumarin based derivatives were synthesized according to two schemes. All the compounds were screened for their acetylcholinesterase inhibitory activity where compound 5b proved to be the most potent AChE inhibitor with (IC (Copyright © 2019 Elsevier Masson SAS. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |